As for other metabolic disorders associated with aberrant mitochondrial bioenergetics, pathogenic AIFM1 mutations cause a large spectrum of clinical outcomes, including fatal encephalomyopathy, ataxia, late-onset neuromyopathy, and mild deafness8. The gene discussed is AIFM1; the disease is Other metabolic disease.